{"id":6270,"date":"2020-02-26T08:22:55","date_gmt":"2020-02-26T08:22:55","guid":{"rendered":"https:\/\/www.dailyrounds.org\/blog\/?p=6270"},"modified":"2020-02-26T09:51:14","modified_gmt":"2020-02-26T09:51:14","slug":"coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit","status":"publish","type":"post","link":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/","title":{"rendered":"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"350\" src=\"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit.png\" alt=\"\" class=\"wp-image-6271\" srcset=\"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit.png 600w, https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-300x175.png 300w, https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-500x292.png 500w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">One of the world&#8217;s largest ibuprofen producers, IOL Chemicals and Pharmaceuticals is about to experience their best month in more than two years. Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller, there&#8217;ll be a supply gap and the company expects to get the benefit.<br>The India based firm in Ludhiana supplies about a third of the world\u2019s requirement of the drug, with ten per cent coming from China\u2019s Hubei Biocause Pharmaceutical Co. According to Vijay Kumar Garg, joint managing director of IOL, the prices of ibuprofen have risen by $3 per kilogram to about $18 over the past few weeks and may hit $20 if supplies from Hubei remain unavailable. <br>Also, he estimates that IOL\u2019s revenue will rise about 25 per cent to 21 billion rupees in the year through March 31, with exports contributing roughly a third. As it has a long term contract with the local companies, they don\u2019t expect any changes to local prices of ibuprofen.  IOL, which counts top Indian drug makers Abbott India Ltd., Cipla Ltd., Dr Reddy\u2019s Laboratories Ltd. among its clients also adds that they don\u2019t want to take undue advantage of the situation. <br>&#8220;We expect a certain higher price but don\u2019t want to force people,&#8221; said  Garg. IOL can manufacture 12,000 tons of ibuprofen each year at its factory in the northern Indian state of Punjab. The plant is currently running at 80% production, Garg said.<br> IOL\u2019s shares have risen 43%, to 254.75 rupees in February and are headed for their best month since October 2017.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: Economic Times. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>One of the world&#8217;s largest ibuprofen producers, IOL Chemicals and Pharmaceuticals is about to experience their best month in more than two years. Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller, there&#8217;ll be a supply gap and the company expects to get the benefit.The India based firm in [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":6275,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-6270","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit - DailyRounds<\/title>\n<meta name=\"description\" content=\"Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller Ibuprofen, there&#039;ll be a supply gap and the company expects to get the benefit.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit - DailyRounds\" \/>\n<meta property=\"og:description\" content=\"Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller Ibuprofen, there&#039;ll be a supply gap and the company expects to get the benefit.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyRounds\" \/>\n<meta property=\"article:published_time\" content=\"2020-02-26T08:22:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-02-26T09:51:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Daily Rounds\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Daily Rounds\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/\"},\"author\":{\"name\":\"Daily Rounds\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#\\\/schema\\\/person\\\/7069ce4ec99a7efe148df373369c9200\"},\"headline\":\"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit\",\"datePublished\":\"2020-02-26T08:22:55+00:00\",\"dateModified\":\"2020-02-26T09:51:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/\"},\"wordCount\":274,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/\",\"name\":\"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit - DailyRounds\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png\",\"datePublished\":\"2020-02-26T08:22:55+00:00\",\"dateModified\":\"2020-02-26T09:51:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#\\\/schema\\\/person\\\/7069ce4ec99a7efe148df373369c9200\"},\"description\":\"Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller Ibuprofen, there'll be a supply gap and the company expects to get the benefit.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png\",\"contentUrl\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/wp-content\\\/uploads\\\/2020\\\/02\\\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png\",\"width\":600,\"height\":350,\"caption\":\"Coronavirus Threat\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/\",\"name\":\"DailyRounds\",\"description\":\"Largest academic Doctors network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/#\\\/schema\\\/person\\\/7069ce4ec99a7efe148df373369c9200\",\"name\":\"Daily Rounds\",\"url\":\"https:\\\/\\\/www.dailyrounds.org\\\/blog\\\/author\\\/doctors-of-dailyrounds\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit - DailyRounds","description":"Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller Ibuprofen, there'll be a supply gap and the company expects to get the benefit.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/","og_locale":"en_US","og_type":"article","og_title":"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit - DailyRounds","og_description":"Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller Ibuprofen, there'll be a supply gap and the company expects to get the benefit.","og_url":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/","og_site_name":"DailyRounds","article_published_time":"2020-02-26T08:22:55+00:00","article_modified_time":"2020-02-26T09:51:14+00:00","og_image":[{"width":600,"height":350,"url":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png","type":"image\/png"}],"author":"Daily Rounds","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Daily Rounds","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#article","isPartOf":{"@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/"},"author":{"name":"Daily Rounds","@id":"https:\/\/www.dailyrounds.org\/blog\/#\/schema\/person\/7069ce4ec99a7efe148df373369c9200"},"headline":"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit","datePublished":"2020-02-26T08:22:55+00:00","dateModified":"2020-02-26T09:51:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/"},"wordCount":274,"commentCount":0,"image":{"@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/","url":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/","name":"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit - DailyRounds","isPartOf":{"@id":"https:\/\/www.dailyrounds.org\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#primaryimage"},"image":{"@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png","datePublished":"2020-02-26T08:22:55+00:00","dateModified":"2020-02-26T09:51:14+00:00","author":{"@id":"https:\/\/www.dailyrounds.org\/blog\/#\/schema\/person\/7069ce4ec99a7efe148df373369c9200"},"description":"Since the prolonged shutdown of China\u2019s Hubei province boosts the prices of the non-prescription painkiller Ibuprofen, there'll be a supply gap and the company expects to get the benefit.","breadcrumb":{"@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#primaryimage","url":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png","contentUrl":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png","width":600,"height":350,"caption":"Coronavirus Threat"},{"@type":"BreadcrumbList","@id":"https:\/\/www.dailyrounds.org\/blog\/coronavirus-lockdown-in-china-top-indian-ibuprofen-maker-expects-benefit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.dailyrounds.org\/blog\/"},{"@type":"ListItem","position":2,"name":"Coronavirus lockdown in China: Top Indian Ibuprofen maker expects benefit"}]},{"@type":"WebSite","@id":"https:\/\/www.dailyrounds.org\/blog\/#website","url":"https:\/\/www.dailyrounds.org\/blog\/","name":"DailyRounds","description":"Largest academic Doctors network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dailyrounds.org\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.dailyrounds.org\/blog\/#\/schema\/person\/7069ce4ec99a7efe148df373369c9200","name":"Daily Rounds","url":"https:\/\/www.dailyrounds.org\/blog\/author\/doctors-of-dailyrounds\/"}]}},"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p5KbfC-1D8","jetpack_featured_media_url":"https:\/\/www.dailyrounds.org\/blog\/wp-content\/uploads\/2020\/02\/Coronavirus-lockdown-in-China_-Top-Indian-Ibuprofen-maker-expects-benefit-1.png","_links":{"self":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts\/6270","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/comments?post=6270"}],"version-history":[{"count":2,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts\/6270\/revisions"}],"predecessor-version":[{"id":6274,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/posts\/6270\/revisions\/6274"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/media\/6275"}],"wp:attachment":[{"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/media?parent=6270"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/categories?post=6270"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dailyrounds.org\/blog\/wp-json\/wp\/v2\/tags?post=6270"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}